Guzzini F, Angiolini F, Cazzaniga L, Gasparini P, Milvio E, Mosconi L
Servizio di Accettazione e PS, USSL 9, Ospedale, Saronno, Varese.
Recenti Prog Med. 1994 Mar;85(3):182-5.
A case is reported of hemolytic anemia following rifampicin administration and complicated by acute renal failure. Furthermore clotting analyses suggested a slight disseminated intravascular coagulation, very likely activated by hemolysis products. Both hemolysis and renal function impairment subsided spontaneously, after the sole withdrawal of rifampin. Direct antiglobulin test became negative within a few days, while an indirect Coomb's test was demonstrated persistently with the patient's serum using red blood cells sensitized in vitro with the drug. Otherwise from all reports in the literature, the patient developed an acute hemolytic anemia while on daily therapy and as many as twenty years after a previous treatment with rifampicin. Mechanisms of drug-induced immune hemolytic anemia and acute nephropathy are discussed (formation of drug-antibody complexes, which adhere on the red blood cells surface and are able to fix complement and induce intravascular hemolysis; tubular necrosis due to hemoglobinuria or immuno-mediated interstitial nephritis).
报告了1例服用利福平后发生溶血性贫血并并发急性肾衰竭的病例。此外,凝血分析提示有轻微的弥散性血管内凝血,很可能是由溶血产物激活所致。仅停用利福平后,溶血和肾功能损害均自发缓解。直接抗球蛋白试验在数天内转为阴性,而使用经该药物体外致敏的红细胞进行间接库姆斯试验时,患者血清持续呈阳性。与文献中的所有报道不同,该患者在每日治疗期间以及上次使用利福平治疗多达20年后发生了急性溶血性贫血。本文讨论了药物性免疫性溶血性贫血和急性肾病的机制(药物-抗体复合物的形成,其黏附于红细胞表面并能够固定补体并诱导血管内溶血;血红蛋白尿或免疫介导的间质性肾炎导致的肾小管坏死)。